Back to Top Skip to main content

Policies

Find Military Health Affairs and Defense Health Agency policy documents.

If you're having trouble finding what you're looking for, consider using fewer words in your search criteria. Results are limited to content that matches all terms in the search field.

We found - potentially matching ""

Specify Date Range (Optional):
Select Content Types (Optional):
Current Filters. Click a Filter to Remove It
Date Range:

DHA AI 8900.01: Guidance for Conducting Surveys and Other Information Collections (SOICs)

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes a Defense Health Agency (DHA) Component Information Collection Program, policy, and procedures necessary to license SOIC, that require responses from DHA personnel and from all organizations that fall under the administration, direction, and control of the DHA. The goal of the program is to minimize redundancy, cost, and burden and improve quality of information being collected by DHA personnel and reported in and outside the organization.

  • Identification #: DHA AI 8900.01
  • Date: 7/4/2020
  • Type: Administrative Instructions
  • Topics: N/A

DHA-PI 6040.05: Enterprise Processes for Translating Defense Health Program (DHP) Funded Research into Standards of Clinical Trauma Care across the DoD

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), establishes the Defense Health Agency’s (DHA) procedures for translating Defense Health Program (DHP)-funded research into standards of care throughout the Defense Trauma Enterprise (DTE).

  • Identification #: DHA PI 6040.05
  • Date: 6/26/2020
  • Type: DHA Procedural Instruction
  • Topics: N/A

DHA-PI 6000.02: Healthcare Technology Management (HTM) Medical Devices and Equipment (MDE) Requirements Management for Military Medical Treatment Facilities (MTFs)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), establishes the Defense Health Agency’s (DHA) process to manage Medical Devices and Equipment (MDE) requirements for Military Medical Treatment Facilities (MTFs) and other lines of business across the Military Health System (MHS), enhances readiness, enables trusted patient care, and increases efficiency through world-class health technology delivery.

  • Identification #: DHA PI 6000.02
  • Date: 6/15/2020
  • Type: DHA Procedural Instruction
  • Topics: N/A

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: N/A

DHA IPM 19-004: Utilization of the Case Management (CM) Registry (Active and Screening) for Military Health System (MHS) Beneficiaries

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s (DHA) procedures to: Outline responsibilities for MHS and Service Department CM personnel to utilize the CM Screening Registry; Identify requirements to utilize CM coding in alignment with current MHS CM coding guidance; and Require the use of standardized Adult and Pediatric Tri-Service Workflow (TSWF) forms for CM documentation (inclusive of telephonic, virtual, or face to face screening) located within AHLTA system and future Electronic Health Record MHS GENESIS

DHA IPM 18-012: The DoD Medical Ethics Program (DoDMEP) in the Military Health System (MHS) - Extended

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (k), establishes Defense Health Agency’s (DHA) procedures that: • Apply to Active Duty Service members, namely Active Component members and Reserve Component members on active duty for a period of more than 30 days, who, hereafter, are referred to collectively as Active Duty Service members (References (e) and (f)). • Establish a set of common guidelines, standards, and procedures governing the DoDMEP for military health care personnel in all locations. • Outline implementing procedures for DHA collaboration with the DoDMEP office, to be known as the DoD Medical Ethics Center (DMEC), which is to operate under the direction of the President of the Uniformed Services University of the Health Sciences (USUHS). • Implement guidance for the DoD mission, vision, guiding principles of the DoDMEP (DMEC) as set forth in Reference (g) and delineate areas of responsibility between the DHA and USUHS, including: o The provision of medical ethics education and training (E&T) to health care providers and other health care personnel; o Creation and maintenance of a DMEC portal; and o Medical ethics consultation services to MHS health care personnel across all settings. • This DHA-IPM is effective immediately and will expire effective 12 months from the date of issue.

DHA IPM 18-016: DHA IPM 18 016 Medical Coding of the DoD Health Records

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (s): • Establishes the Defense Health Agency’s (DHA) procedures for centralized oversight, standardized operations, and ensured quality and performance for the coding of DoD Health Records. • This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction. This DHA-IPM will expire 12 months from the date of issue.

DHA-IPM 20-003: DoD Procurement of Ruminant Products from Overseas Origin

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s procedures to authorize the procurement of all ruminant meat (beef, sheep, goat, bison, etc.) and edible products from ruminants of overseas origin. DoD procurement of ruminant meat and meat products will align with current United States Department of Agriculture (USDA) restrictions and residual risk mitigation measures for Bovine Spongiform Encephalopathy (BSE).

  • Identification #: 20-003
  • Date: 4/10/2020
  • Type: DHA Interim Procedures Memorandum
  • Topics: N/A

Elective Surgical, Invasive, and Dental Procedures in Military Treatment Facilities

Policy

This memorandum directs all Military Treatment Facility (MTF) and Dental Treatment Facility (DTF) Commanders and Directors to immediately postpone all elective surgeries, invasive procedures, and dental procedures performed on beneficiaries of the MTFs and DTFs with the exceptions outlined below. This includes aerosol-producing procedures, such as endoscopies, bronchoscopies, pulmonary function tests, and sleep continuous positive airway pressure (CPAP) titrations. This policy is effective March 31, 2020, and will remain in place for 60 days.

  • Identification #: N/A
  • Date: 3/24/2020
  • Type: Memorandums
  • Topics: N/A

DHA IPM 20-002: Southern Hemisphere Influenza Vaccination Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s (DHA) procedures to implement instructions, assign responsibilities, and prescribe procedures for the Southern Hemisphere Influenza Vaccination Program. All Active Duty, Selected Reserve, and National Guard members receive an annual influenza vaccination. Personnel who are traveling to, conducting a permanent change of station to, or are located in the Southern Hemisphere will receive the Southern Hemisphere influenza vaccine or obtain an exemption (e.g., medical or administrative) in accordance with guidance in paragraph 6.a. of Attachment 2. Military personnel residing in the Southern Hemisphere who have received the Southern Hemisphere influenza vaccine in accordance with Appendix 1, meet the annual influenza immunization requirement.

(DTM)-19-004 -Military Service by Transgender Persons and Persons with Gender Dysphoria (Change 1)

Policy

Implements the policy in the February 22, 2018 Secretary of Defense Memorandum and the February 2018 DoD Report and Recommendations on Military Service by Transgender Persons, assigns responsibilities, and prescribes procedures regarding the standards for accession, retention, separation, in-service transition, and medical care for Service members and applicants with gender dysphoria, as applicable. This DTM is effective April 12, 2019. This DTM will be incorporated into DoDIs1300.28, 1332.14, 1332.30, and 6130.03, and supersedes any contradictory guidance in those publications. This DTM will expire effective September 12, 2020.

DHA-PI 6025.32: MHS GENESIS Medical Device

Policy

This DHA-PI establishes Defense Health Agency’s (DHA) procedures to provide key stakeholders’ responsibilities for connecting medical devices to MHS GENESIS; establish clinical expectations for connecting medical devices to MHS GENESIS; provide references for MTFs to use in procuring medical devices that will be connected to MHS GENESIS; and provide process for MTFs to elevate medical device connection issues related to MHS GENESIS.

DHA-PI 5020.01: New Integrated Capabilities Portfolio

Policy

This DHA-PI ensures alignment of the Integrated Capabilities Portfolio (ICP) process with the National Military Strategy, support the Quadruple Aim , and ensure every resource is supporting the critical initiatives of the DHA. This effort ensures that every dollar spent provides value back to the Military Health System (MHS), improves efficiency and effectiveness, and supports readiness and health.

  • Identification #: DHA PI 5020.01
  • Date: 3/11/2020
  • Type: DHA Procedural Instruction
  • Topics: N/A

DHA-PI 8400.01: CyberLOG MDE Risk Management

Policy

This DHA-PI establishes centralized processes and procedures to implement and maintain RMF authorization and cybersecurity for MDE across the Military Health System (MHS) through the Defense Health Agency (DHA) CyberLOG. This DHA-PI develops the standard DHA cybersecurity requirements process to translate and identify MTFs MDE planning requirements; implements a standard cybersecurity approach to analyze, evaluate, and manage MDE planning, procurement, and sustainment to meet cybersecurity requirements through the RMF process; executes the DHA RMF authorization process within DHA activities for MDE purchased with DHP funds; and maintains an acceptable security baseline for MDE.

  • Identification #: DHA PI 8400.01
  • Date: 3/2/2020
  • Type: DHA Procedural Instruction
  • Topics: N/A

DHA AI 8900.01: Guidance for Conducting Surveys and Other Information Collections (SOICs)

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes a Defense Health Agency (DHA) Component Information Collection Program, policy, and procedures necessary to license SOIC, that require responses from DHA personnel and from all organizations that fall under the administration, direction, and control of the DHA. The goal of the program is to minimize redundancy, cost, and burden and improve quality of information being collected by DHA personnel and reported in and outside the organization.

  • Identification #: DHA AI 8900.01
  • Date: 7/4/2020
  • Type: Administrative Instructions
  • Topics: N/A

DHA-PI 6040.05: Enterprise Processes for Translating Defense Health Program (DHP) Funded Research into Standards of Clinical Trauma Care across the DoD

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), establishes the Defense Health Agency’s (DHA) procedures for translating Defense Health Program (DHP)-funded research into standards of care throughout the Defense Trauma Enterprise (DTE).

  • Identification #: DHA PI 6040.05
  • Date: 6/26/2020
  • Type: DHA Procedural Instruction
  • Topics: N/A

DHA-PI 6000.02: Healthcare Technology Management (HTM) Medical Devices and Equipment (MDE) Requirements Management for Military Medical Treatment Facilities (MTFs)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), establishes the Defense Health Agency’s (DHA) process to manage Medical Devices and Equipment (MDE) requirements for Military Medical Treatment Facilities (MTFs) and other lines of business across the Military Health System (MHS), enhances readiness, enables trusted patient care, and increases efficiency through world-class health technology delivery.

  • Identification #: DHA PI 6000.02
  • Date: 6/15/2020
  • Type: DHA Procedural Instruction
  • Topics: N/A

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: N/A

DHA IPM 19-004: Utilization of the Case Management (CM) Registry (Active and Screening) for Military Health System (MHS) Beneficiaries

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s (DHA) procedures to: Outline responsibilities for MHS and Service Department CM personnel to utilize the CM Screening Registry; Identify requirements to utilize CM coding in alignment with current MHS CM coding guidance; and Require the use of standardized Adult and Pediatric Tri-Service Workflow (TSWF) forms for CM documentation (inclusive of telephonic, virtual, or face to face screening) located within AHLTA system and future Electronic Health Record MHS GENESIS

DHA IPM 18-012: The DoD Medical Ethics Program (DoDMEP) in the Military Health System (MHS) - Extended

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (k), establishes Defense Health Agency’s (DHA) procedures that: • Apply to Active Duty Service members, namely Active Component members and Reserve Component members on active duty for a period of more than 30 days, who, hereafter, are referred to collectively as Active Duty Service members (References (e) and (f)). • Establish a set of common guidelines, standards, and procedures governing the DoDMEP for military health care personnel in all locations. • Outline implementing procedures for DHA collaboration with the DoDMEP office, to be known as the DoD Medical Ethics Center (DMEC), which is to operate under the direction of the President of the Uniformed Services University of the Health Sciences (USUHS). • Implement guidance for the DoD mission, vision, guiding principles of the DoDMEP (DMEC) as set forth in Reference (g) and delineate areas of responsibility between the DHA and USUHS, including: o The provision of medical ethics education and training (E&T) to health care providers and other health care personnel; o Creation and maintenance of a DMEC portal; and o Medical ethics consultation services to MHS health care personnel across all settings. • This DHA-IPM is effective immediately and will expire effective 12 months from the date of issue.

DHA IPM 18-016: DHA IPM 18 016 Medical Coding of the DoD Health Records

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (s): • Establishes the Defense Health Agency’s (DHA) procedures for centralized oversight, standardized operations, and ensured quality and performance for the coding of DoD Health Records. • This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction. This DHA-IPM will expire 12 months from the date of issue.

DHA-IPM 20-003: DoD Procurement of Ruminant Products from Overseas Origin

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s procedures to authorize the procurement of all ruminant meat (beef, sheep, goat, bison, etc.) and edible products from ruminants of overseas origin. DoD procurement of ruminant meat and meat products will align with current United States Department of Agriculture (USDA) restrictions and residual risk mitigation measures for Bovine Spongiform Encephalopathy (BSE).

  • Identification #: 20-003
  • Date: 4/10/2020
  • Type: DHA Interim Procedures Memorandum
  • Topics: N/A

Elective Surgical, Invasive, and Dental Procedures in Military Treatment Facilities

Policy

This memorandum directs all Military Treatment Facility (MTF) and Dental Treatment Facility (DTF) Commanders and Directors to immediately postpone all elective surgeries, invasive procedures, and dental procedures performed on beneficiaries of the MTFs and DTFs with the exceptions outlined below. This includes aerosol-producing procedures, such as endoscopies, bronchoscopies, pulmonary function tests, and sleep continuous positive airway pressure (CPAP) titrations. This policy is effective March 31, 2020, and will remain in place for 60 days.

  • Identification #: N/A
  • Date: 3/24/2020
  • Type: Memorandums
  • Topics: N/A

DHA IPM 20-002: Southern Hemisphere Influenza Vaccination Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s (DHA) procedures to implement instructions, assign responsibilities, and prescribe procedures for the Southern Hemisphere Influenza Vaccination Program. All Active Duty, Selected Reserve, and National Guard members receive an annual influenza vaccination. Personnel who are traveling to, conducting a permanent change of station to, or are located in the Southern Hemisphere will receive the Southern Hemisphere influenza vaccine or obtain an exemption (e.g., medical or administrative) in accordance with guidance in paragraph 6.a. of Attachment 2. Military personnel residing in the Southern Hemisphere who have received the Southern Hemisphere influenza vaccine in accordance with Appendix 1, meet the annual influenza immunization requirement.

(DTM)-19-004 -Military Service by Transgender Persons and Persons with Gender Dysphoria (Change 1)

Policy

Implements the policy in the February 22, 2018 Secretary of Defense Memorandum and the February 2018 DoD Report and Recommendations on Military Service by Transgender Persons, assigns responsibilities, and prescribes procedures regarding the standards for accession, retention, separation, in-service transition, and medical care for Service members and applicants with gender dysphoria, as applicable. This DTM is effective April 12, 2019. This DTM will be incorporated into DoDIs1300.28, 1332.14, 1332.30, and 6130.03, and supersedes any contradictory guidance in those publications. This DTM will expire effective September 12, 2020.

DHA-PI 6025.32: MHS GENESIS Medical Device

Policy

This DHA-PI establishes Defense Health Agency’s (DHA) procedures to provide key stakeholders’ responsibilities for connecting medical devices to MHS GENESIS; establish clinical expectations for connecting medical devices to MHS GENESIS; provide references for MTFs to use in procuring medical devices that will be connected to MHS GENESIS; and provide process for MTFs to elevate medical device connection issues related to MHS GENESIS.

DHA-PI 5020.01: New Integrated Capabilities Portfolio

Policy

This DHA-PI ensures alignment of the Integrated Capabilities Portfolio (ICP) process with the National Military Strategy, support the Quadruple Aim , and ensure every resource is supporting the critical initiatives of the DHA. This effort ensures that every dollar spent provides value back to the Military Health System (MHS), improves efficiency and effectiveness, and supports readiness and health.

  • Identification #: DHA PI 5020.01
  • Date: 3/11/2020
  • Type: DHA Procedural Instruction
  • Topics: N/A

DHA-PI 8400.01: CyberLOG MDE Risk Management

Policy

This DHA-PI establishes centralized processes and procedures to implement and maintain RMF authorization and cybersecurity for MDE across the Military Health System (MHS) through the Defense Health Agency (DHA) CyberLOG. This DHA-PI develops the standard DHA cybersecurity requirements process to translate and identify MTFs MDE planning requirements; implements a standard cybersecurity approach to analyze, evaluate, and manage MDE planning, procurement, and sustainment to meet cybersecurity requirements through the RMF process; executes the DHA RMF authorization process within DHA activities for MDE purchased with DHP funds; and maintains an acceptable security baseline for MDE.

  • Identification #: DHA PI 8400.01
  • Date: 3/2/2020
  • Type: DHA Procedural Instruction
  • Topics: N/A
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 76

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.